New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2014
07:23 EDTSNSS, DNDNSunesis appoints Joseph DePinto as Chief Commercial Officer
Sunesis Pharmaceuticals (SNSS) announced the appointment of Joseph DePinto to the newly created position of executive vice president and Chief Commercial Officer. Prior to joining Sunesis, DePinto was Executive Vice President, Global Commercial Operations at Dendreon (DNDN).
News For SNSS;DNDN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 16, 2014
09:13 EDTDNDNNICE says Dendreon drug too expensive for prostate cancer use
Subscribe for More Information
October 10, 2014
05:47 EDTSNSSStocks with implied volatility movement; SNSS GPOR
Subscribe for More Information
October 8, 2014
07:19 EDTSNSSCBI to hold a conference
Subscribe for More Information
05:45 EDTSNSSStocks with implied volatility movement; GTAT SNSS
Stocks with implied volatility movement; GT Advanced (GTAT) 403, Sunesis (SNSS) 164 according to iVolatility.
October 7, 2014
10:02 EDTSNSSOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:50 EDTSNSSSunesis downgraded to Sell from Buy at UBS
Subscribe for More Information
06:41 EDTSNSSSunesis downgraded to Hold from Buy at Cantor
Cantor Fitzgerald downgraded Sunesis to Hold after removing Qinprezo from its model following the Phase III VALOR trial failure. The firm thinks the stock will be capped to a multiple of cash in the near-term, or roughly $2 per share. Sunesis was also downgraded this morning at Roth Captial.
06:22 EDTSNSSSunesis downgraded to Neutral from Buy at Roth Capital
Subscribe for More Information
06:09 EDTSNSSStocks with implied volatility below IV index mean; ADHD SNSS
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use